5 Most Promising Mid-Cap Stocks According to Analysts

Page 5 of 5

1. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Number of Hedge Fund Holders: 43

One-Year Price Target: $201.39

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) ranks 1st in our list of the most promising mid-cap stocks according to analysts. In December, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) jumped after Goldman Sachs upgraded it to Buy from Neutral, citing a positive outlook for its operating margins.

Goldman’s Madhu Kumar believes Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has performed in line with the management’s guidance.

He believes Jazz Pharmaceuticals plc (NASDAQ:JAZZ) would be able to “maintain these operating margin improvements into 2025, even without substantial top-line growth from key franchises.”

You can also take a peek at 10 Hot Tech Stocks To Buy Now and 10 Hot Healthcare Stocks To Buy Now.

Page 5 of 5